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20 Structured Abstract
21 Objective
22 We examined whether Medicaid-enrolled women in CenteringPregnancy group prenatal care had 
23 higher rates of 1) postpartum visit attendance and 2) postpartum uptake of contraceptives, 
24 compared to women in individual prenatal care.
25 Study design
26 We linked birth certificates and Medicaid claims for women receiving group prenatal care in 18 
27 healthcare practices and applied preferential-within cluster propensity score methods to identify 
28 a comparison group, accounting for the nested data structure by practice. We examined five 
29 standardized, claims-based outcomes: postpartum visit attendance; contraception within 3 days; 
30 and any contraception, long-acting reversible contraception (LARC), and permanent 
31 contraception within eight weeks. We assessed outcomes using logistic regression for two 
32 treatment levels: (1) any group attendance compared to no group attendance and (2) attendance 
33 at five or more group sessions to at least five prenatal care visits, including crossovers attending 
34 fewer than five group sessions (minimum threshold analysis). 
35 Results
36 Women attending at least five group sessions had higher rates of postpartum visit attendance 
37 (71.5% vs. 67.5%, p<.05). Women with any group attendance (N=2,834) were more likely than 
38 women with individual care only (N=13,088) to receive contraception within 3 days (19.8% vs. 
39 16.9%, p<.001) and to receive a LARC within eight weeks’ postpartum (18.0% vs. 15.2%, 
40 p<.001). At both treatment levels, group participants were less likely to elect permanent 
3
41 contraception (5.9% vs. 7.8%, p<0.001). Women meeting the five-visit group threshold were not 
42 more likely to initiate contraception or LARCs within 8 weeks’ postpartum.
43 Conclusion
44 Participation in at least five group compared to five individual prenatal care visits is associated 
45 with greater rates of postpartum visit attendance. Additional engagement and education in group 
46 prenatal care may influence postpartum visit attendance.
47 Implications
48 Planning for postpartum care and contraception during prenatal care is an important strategy for 
49 connecting women to postpartum healthcare. Regardless of prenatal care model, women have 
50 low uptake of contraception in the postpartum period. Increased use of group prenatal care with 
51 its scheduled family planning discussion may help to increase postpartum contraceptive uptake. 
52 This benefit is dependent on availability of postpartum contraception options. 
53 Keywords
54 Group prenatal care, CenteringPregnancy, postpartum visits, postpartum contraception choice
55
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59 1. Introduction 
60 Comprehensive postpartum care, including family planning, is a critical preventive health 
61 service that promotes optimal health for mother and infant [1]. Yet, as many as 40-50% of 
62 women do not attend a postpartum visit 4-6 weeks after birth despite current guidelines [2]. Low 
63 attendance rates are particularly common among women with limited resources, including those 
64 with Medicaid [3–5]. This lack of engagement with  postpartum care risks delay in addressing 
65 peri- and postnatal health issues, missed opportunities for identifying problems with the physical 
66 and mental adjustments to motherhood, and planning for the healthy timing and spacing of future 
67 pregnancies [6,7]. Acknowledging the historical context of fertility control and sterilization 
68 abuse, current best practice guidelines emphasize that each woman receive information on the 
69 full range of contraception options so she can make a well-informed, individualized choice [2,8]. 
70 The importance of measuring patient engagement around these two metrics – postpartum visit 
71 attendance and contraceptive use – has been recognized by the National Committee for Quality 
72 Assurance (NCQA) and the Office of Population Affairs who have each developed clinical 
73 performance measures to support quality improvement efforts aimed at increasing utilization of 
74 these services [9,10].  
75 The CenteringPregnancyTM model of group prenatal care addresses the topics of family 
76 planning and postpartum care explicitly and in greater detail compared with traditional, 
77 individual prenatal care [11]. Medical providers deliver educational content through facilitating 
78 group discussion, which fosters patient engagement and encourages women to ask questions.  
79 This model has overall demonstrated positive outcomes, including higher rates of prenatal care 
80 use and satisfaction, improvements in preterm birth rates, and higher rates of breastfeeding [12–
81 15]. One of the curriculum development goals was to optimize care and support for women in 
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82 the postpartum period and address postpartum contraceptive methods [16].  Several smaller 
83 observational studies have noted that group participants have higher rates of postpartum visit 
84 attendance, are more likely to utilize contraceptive care visits, and are more likely to choose 
85 long-acting, reversible contraception (LARC) [17–19].
86 Larger studies with standardized measures and more rigorous approaches to addressing 
87 selection bias are needed to understand CenteringPregnancy’s impact on these metrics.  We 
88 investigate this research gap through comparing these standardized quality of care measures 
89 using Medicaid claims in the context of an 18-site state-supported expansion of 
90 CenteringPregnancy group prenatal care.  
91 2. Methods 
92 2.1 Objectives
93 This study had two main objectives: to explore whether Medicaid-enrolled women 
94 receiving group compared to individual prenatal care had 1) higher rates of postpartum visit 
95 attendance and 2) were more likely to access contraceptives in the postpartum period, and in 
96 particular, select long-acting reversible contraceptive (LARC) methods. We define LARC 
97 methods as intrauterine devices and implants.
98 2.2 Group Prenatal Care 
99 The CenteringPregnancyTM model of group prenatal care, developed and maintained by 
100 the Centering Healthcare Institute, includes all of the elements of the American College of 
101 Obstetrics and Gynecology’s recommended individual care physical assessment and screening 
102 visits [20].  Prenatal care is provided in ten, two-hour group sessions with six to twelve women 
103 with similar due dates within a 4-6 week range [11,16]. The first 30 minutes of each session is 
104 dedicated to individual, routine medical assessments by the healthcare provider. The remaining 
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105 90 minutes are composed of group discussions and interactive activities facilitated by the 
106 medical care team using a curriculum focused on pregnancy, childbirth, and parenting-related 
107 topics [20]. Women will also attend traditional, individual prenatal care visits early in pregnancy 
108 (i.e. before enrolling in group), late in pregnancy (i.e. after the 10th session and before birth), as 
109 replacement for a missed group session, and if they require additional individualized follow-up. 
110 2.3 Setting
111 Launched in 2012, the South Carolina CenteringPregnancy Expansion Project provides 
112 training, technical assistance, and start-up funds to obstetric practices implementing the 
113 CenteringPregnancyTM model. Practices joined the initiative in several cohorts over seven years. 
114 At the time of publication, twenty-four practices from across the state were participating in the 
115 project [21]. 
116 2.4 Data Sources and Sample Population 
117 This study analyzes birth certificate data matched with Medicaid claims data for births 
118 occurring in 18 sites between 2013 and 2017. These practices represent academic medical 
119 centers, family medicine practices, and private OB-GYN practices where at least one 
120 CenteringPregnancy group has had all mothers deliver babies and vital statistics birth certificate 
121 data has been processed. The South Carolina Revenue and Fiscal Affairs Office (RFA) matched 
122 practice-provided group patient lists to birth certificates and identified a comparison group of 
123 deliveries, matched by the National Provider Identifier (NPI) of the delivering provider, delivery 
124 month, and year. 
125 Our sample population included women who had viable pregnancies during the study 
126 period whose deliveries were covered by Medicaid. Women with more than one birth (including 
127 multiple gestation) during the study period were excluded, due to limitations in the de-identified 
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128 claims data to match maternal claims with specific births. This research was approved by the 
129 institutional review board at Prisma Health which did not require informed consent for the use of 
130 preexisting administrative data. The authors report no conflict of interest. 
131 2.5 Treatment exposures
132 We defined two levels of prenatal care use for comparisons a priori:  1) any group 
133 attendance to no group attendance and 2) attendance at five or more group sessions to attendance 
134 at five or more prenatal care visits (minimum threshold analysis). The “five or more prenatal 
135 visits” cohort includes crossovers to individual care attending fewer than five group sessions, 
136 reflecting typical patterns of care. Other studies have used a five visit threshold [13,22]. The 
137 CenteringPregnancy curriculum covers postpartum family planning in session four, and group 
138 facilitators’ experience suggests attending 50% of group sessions is an effective dose as groups 
139 usually become more engaged and cohesive over time, most women who drop out do so after 
140 one or two sessions, and few complete all 10 sessions. Women attending less than 50% of groups 
141 may have experienced scheduling barriers, have risk factors that led them to switch back to 
142 individual visits, or may have decided the group setting did not suit their needs. In our sample, 
143 26% of CenteringPregnancy participants attended between one and four group sessions, 20% 
144 attended 5-6 group sessions, 47% attended 7-9 sessions; and 7% attended all ten sessions.
145 2.6 Statistical Analysis
146 Because randomizing women to prenatal care model was not possible in this retrospective 
147 cohort analysis, we developed propensity scores to match women participating in group to a 
148 similar cohort of women receiving individual prenatal care to reduce observable differences (e.g. 
149 that may indicate selection bias). This technique helps ensure that identifiable differences 
150 between the groups are a result of the treatment received [23,24].  All birth certificate variables 
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151 were assessed to determine their suitability to contribute to the propensity score estimation. We 
152 identified matching variables through bivariate correlation analysis with each predictor variable 
153 vs. the treatment variable (group care) and each outcome of interest. If the correlation between a 
154 predictor and treatment or any outcome was greater than |0.10|, and/or the literature supported its 
155 inclusion, then the predictor was included as a matching variable [25]. For example, diabetes, 
156 hypertension, and body mass index (BMI) were included because of unadjusted variation 
157 between the cohorts and potential influence of pregnancy health conditions on increased 
158 likelihood of postpartum visit attendance [3].  The matching variables included in the final 
159 propensity scores were: parity, Kotelchuck index (an adequacy of prenatal care measure 
160 combining prenatal care initiation with the ratio of actual to expected number of prenatal care 
161 visits between entry to care and delivery date) [26], cesarean delivery, pre-pregnancy diabetes, 
162 gestational diabetes, pre-pregnancy hypertension, gestational hypertension, body mass index 
163 (BMI), mother’s age, mother’s education, mother’s race, delivery year, low birth weight birth, 
164 and preterm birth.  
165 We then used a preferential-within matching technique—matching with similar propensity scores 
166 within the same practice to account for the nested nature of the data within sites. An algorithm 
167 was used to match any group care participant without a within-site match to an individual care 
168 patient at a different site. This approach reduces the number of unmatched cases that result from 
169 only matching within practice sites and improves the balance of covariates and potential 
170 cofounders relative to a pooled matching approach [27,28]. As mentioned above, in the 
171 minimum threshold analysis, the control group includes women with individual care visits who 
172 also had one to four group care sessions.  Allowing women who crossed over to individual care 
9
173 from CenteringPregnancy to remain in the minimum threshold analysis results in a control group 
174 more similar to the treatment group of women attending five or more group sessions.
175
176 2.7 Outcome Variables
177 We examined five outcomes using Medicaid claims measures: postpartum visit 
178 attendance, ‘most or moderately effective’ contraception within 3 days of delivery, ‘most or 
179 moderately effective’ contraception within 8 weeks, and permanent contraception or LARC 
180 uptake within 8 weeks. ‘Postpartum visit attendance’ was defined as any postpartum visit 
181 occurring between 21 and 56 days postpartum. The postpartum visit attendance measure used the 
182 published methodology from the National Committee for Quality Assurance’s Healthcare 
183 Effectiveness Data and Information Set (HEDIS) [9]. ‘Most or moderately effective’ refers to the 
184 initiation of a healthcare prescribed contraceptive method—including oral contraceptives, 
185 injectables, the patch, the ring, diaphragm, LARCs (i.e. implant and IUD), and permanent 
186 contraception —within 3 days or 8 weeks postpartum. ‘LARC uptake within 8 weeks’ refers to 
187 the insertion of an IUD or implant within 8 weeks postpartum.  These contraceptive measures 
188 used the published specifications for health care claims from the Department of Health and 
189 Human Services’ Office of Population Affairs [10]. These standardized measures were selected 
190 to assure consistency in reporting and comparability with published reports. The impact of group 
191 care on each outcome was examined using simple logistic regression models with the matched 
192 group and individual care cohorts. The analyses were repeated for two treatment levels (section 
193 2.5).
194 3. Results 
195 3.1 Population Characteristics 
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196 CenteringPregnancy (N=2,834) and individual care (N=13,088) participants differed 
197 across demographic characteristics and adequacy of prenatal care (Table 1). Of note, group 
198 participants were younger, had lower levels of educational attainment, and were more likely to 
199 be Hispanic. This group also had a higher percentage of first-time mothers and began prenatal 
200 care earlier. Both groups also differed across risk factors for poor birth outcomes. Group 
201 participants were less likely to have a BMI greater than 45, pre-pregnancy diabetes, gestational 
202 diabetes, pre-pregnancy hypertension, gestational hypertension, or a previous preterm birth. This 
203 lower risk profile contributed to better birth outcomes, as group participants had lower rates of 
204 cesarean deliveries, preterm births, and low birthweight births.
205 3.2 Logistic Regression Analyses
206 The propensity-matching procedures increased the comparability of the treatment and 
207 comparison groups and met accepted thresholds for balancing groups prior to outcomes analysis 
208 (See Appendix Table 1. Outcomes prior to propensity score matching are shown in Table 2). 
209 Women attending at least one group compared to no group attendance were equally likely to 
210 attend postpartum visits or receive a most or moderately effective contraceptive method within 8 
211 weeks (Table 3). Women attending at least one group were more likely to receive most or 
212 moderately effective contraception within 3 days (19.8% vs. 16.9%, p<.001) and more likely to 
213 receive a LARC within eight weeks’ postpartum (18.0% vs. 15.2%, p<.001). Supplemental 
214 analyses (not shown) indicate that the IUD insertion rates within eight weeks’ postpartum were 
215 similar between cohorts at either treatment level (5.8% for women attending at least one group to 
216 5.1% for women with no group attendance). Implant insertion rates within eight weeks’ 
217 postpartum were higher for women attending at least one group (12.2% vs. 10.1%, p<.01). 
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218 For women meeting at least a five-visit threshold, group participants had higher rates of 
219 postpartum visit attendance (71.5% vs. 67.5%, p<.05). At both treatment exposures, group 
220 participants were less likely to elect permanent contraception (Table 3). 
221 4. Discussion 
222 Group prenatal care participation is associated with greater rates of postpartum visit 
223 attendance for women who attend at least five prenatal care visits. The additional patient 
224 engagement and education in the group setting may positively impact some women’s decisions 
225 to seek postpartum care, but not be sufficient to support low-income women overcoming other 
226 barriers to accessing care such as insufficient care continuity, lack of social support, childcare 
227 and transportation issues, and language barriers [17,29,30]. 
228 Our analyses indicated that women receiving individual prenatal care were more likely to 
229 undergo permanent contraception. Women in the individual care group were older, higher parity, 
230 and more likely to have had a cesarean delivery or a medical condition that makes pregnancy or 
231 childbearing difficult, all of which are factors that influence decisions to undergo permanent 
232 contraception [31,32]. While we matched on observable characteristics, propensity score 
233 methods cannot fully compensate for underlying group differences. These decisions regarding 
234 contraceptive choice may also be influenced by different contraceptive counseling practices 
235 between the two prenatal care models. While women in group prenatal care were less likely to 
236 choose permanent contraception, they were more likely to choose LARC methods.  This may 
237 reflect the impact that facilitated group discussion of family planning options has on improving 
238 women’s knowledge of and comfort with choosing LARC methods of contraception [33,34]. 
239 The relatively small differences and low rates in contraception outcomes suggest the 
240 limitations of prenatal care to support postpartum contraception choice. While South Carolina’s 
12
241 Medicaid reimbursement policy supporting immediate postpartum LARCs went into effect in 
242 2012, we expect adoption and implementation varied during the study period and by provider 
243 (this data was not available) [35,36].  Our preferential within-cluster matching approach controls 
244 statistically for provider differences. Other studies have demonstrated that when knowledge, 
245 cost, and same-day availability barriers are removed, LARC uptake is much greater than 
246 observed in our study [37].
247 Few studies have examined the impact of group prenatal care on women’s postpartum 
248 health and healthcare use. Among women continuously enrolled in Medicaid for 12 months, 
249 group prenatal care participants demonstrated greater utilization rates of Medicaid family 
250 planning program-covered services by six and 12 months postpartum when compared to a 
251 propensity-score matched group of individual care participants [29]. A cluster randomized 
252 control trial of adolescents in New York City found that participants who attended at least half of 
253 their group sessions were less likely to experience rapid repeat pregnancy, used condoms more 
254 frequently, and engaged in fewer acts of unprotected sex [13]. 
255 The observed rates of postpartum visit attendance in the current study are similar to other 
256 published measures with Medicaid populations [3,4,18]. The Healthy People 2020 target for 
257 postpartum visit attendance is 90.1%, using self-reported visit attendance from the Pregnancy 
258 Risk Assessment Monitoring System [38]. While not directly comparable to our study given the 
259 difference in data source (claims vs. self-report), our results indicate a clear opportunity to 
260 increase access to postpartum care for women who have Medicaid coverage for delivery. 
261 4.1 Strengths and Limitations
262 Our study has a number of limitations. Because our datasets are limited to birth certificate 
263 and Medicaid claims, we were unable to control for other variables that may influence women’s 
13
264 choice of prenatal care model, prenatal care attendance, or outcomes. While propensity scores 
265 were used to reduce observable differences that may indicate selection bias, propensity scores do 
266 not address how unmeasured confounding variables might lead to biased results, and cannot fully 
267 compensate for group differences. Such variables could include women’s contraception 
268 knowledge and preferences, and transportation or childcare issues affecting attendance at both 
269 prenatal and postpartum visits. 
270  The claims data was limited to eight weeks’ postpartum. In light of the strong clinical 
271 recommendations that postpartum visits occur within 4-6 weeks, and the availability of 
272 standardized performance measures, eight weeks remains an important timeframe for analysis, 
273 but may miss patients that come for care after this point in time. Contraceptive options such as 
274 condoms, vasectomy, or lactational amenorrhea were not considered as the study used 
275 contraceptive care performance measures—outlined by the Office of Population Affairs—based 
276 on Medicaid claims. 
277 Study strengths include our use of data from 18 practices serving a large, diverse 
278 population (by race, age, and parity) and our examination of outcomes across treatment levels in 
279 relation to engagement in prenatal care.
280 4.2 Public Health Implications
281 Planning for postpartum care and contraception use during prenatal care is an important 
282 strategy for connecting women to postpartum healthcare. Group prenatal care can contribute 
283 modestly to increased use of these services. Additional work to assess impacts of policy and 
284 practice changes, including Medicaid expansion and inpatient postpartum LARC availability and 
285 counseling, is needed to prioritize strategies to increase Medicaid-enrolled women’s postpartum 
286 visit attendance and access to contraception.
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287 Table 1. Characteristics (before propensity score matching) of women in 
288 CenteringPregnancy group prenatal care and individual care, 2013- 2017.
Cohort Demographics (restricted to Medicaid)
Individual prenatal 
care (N=13,088)
Group prenatal 
care 
(N=2,834)
% %
P- Value
Maternal age category <0.01
14-17 3.2 5.1
18-25 48.6 57.4
26-35 41.2 33.9
36-44 6.9 3.6
Maternal education <0.01
< high school 22.7 25.5
high school/GED 36.6 35.5
some college 29.7 27.2
associates or higher 11.0 11.8
Maternal race <0.01
Black 47.0 45.2
White 45.6 41.5
Hispanic 6.1 12.7
Other 1.3 0.6
# Previous live births <0.01
0 36.4 55.1
1 29.8 24.3
2+ 33.8 20.6
Month PNC began (grouped) <0.01
0-2 months 32.5 43.2
3-4 months 44.5 49.3
5+ months 23.1 7.5
Kotelchuck Index <0.01
Inadequate 25.1 8.6
Intermediate 5.4 4.8
Adequate 24.3 21.9
Adequate+ 45.1 64.6
Tobacco use in pregnancy 17.7 13.7 <0.01
Infections during pregnancy 11.4 11.4 0.94
BMI>45 5.3 2.5 <0.01
Prepregnancy diabetes 2.2 0.3 <0.01
Prepregnancy hypertension 4.4 1.8 <0.01
Previous preterm birth 8.5 3.8 <0.01
Gestational diabetes 6.2 4.2 <0.01
15
Gestational hypertension 10.8 12.6 <0.01
Cesarean delivery 31.5 25.1 <0.01
NICU admission 9.4 6.6 <0.01
Preterm birth 10.8 7.9 <0.01
Preterm birth (<32 weeks) 2.1 1.6 0.08
Low birthweight 9.8 7.5 <0.01
Breastfeeding at hospital discharge 67.5 75.7 <0.01
289
290
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291 Table 2. Outcomes (before propensity score matching) of women in CenteringPregnancy 
292 group prenatal care and individual care, 2013- 2017.
Individual prenatal 
care (N=13,088)
Group prenatal 
care 
(N=2,834)
P- Value
% %
Postpartum visit attendance 62.4 68.6 <0.01
Contraception (within 8 weeks postpartum) 49.3 50.1 0.44
Contraception (within 3 days postpartum) 17.3 19.8 <0.01
Permanent contraception (within 8 weeks 
postpartum) 11.3 5.9 <0.01
LARCs (within 8 weeks postpartum) 17.7 18.0 0.77
293
294
295
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296 Table 3. Rate estimates and adjusted odds ratios for postpartum visit and contraception use, by prenatal care type 
 Percent of Pregnancies  
Adjusted Odds Ratio 
 
 
Individual care 
estimate
Group care 
estimate P-value Estimate 95% Confidence interval
Postpartum visit % %    
1+ visit 67.6 68.6 0.58 1.047 (0.99, 1.11)
5+ visits 67.5 71.5 0.01 1.209 (1.13, 1.29)
Contraception (within 3 days postpartum)      
1+ visit 16.9 19.8 0.00 1.215 (1.13, 1.31)
5+ visits 19.7 20.3 0.38 1.037 (0.96, 1.12)
Contraception (within 8 weeks postpartum)      
1+ visit 47.7 50.2 0.06 1.103 (1.04, 1.17)
5+ visits 50.3 50.6 0.75 1.013 (0.95, 1.08)
Permanent contraception (within 8 
weeks postpartum)      
1+ visit 7.8 5.9 0.00 0.742 (0.66, 0.83)
5+ visits 9.2 5.9 0.00 0.621 (0.55, 0.70)
LARCs (within 8 weeks postpartum)      
1+ visit 15.2 18.0 0.00 1.220 (1.13, 1.32)
5+ visits 16.9 18.3 0.34 1.101 (1.01, 1.20)
297 Estimated rates reflect propensity score analysis results, per pregnancy.  Odds ratio <1 indicates higher rates among individual 
298 prenatal care, and an odds ratio >1 indicates higher rates among group prenatal care.  The first pregnancy only within the study period 
299 is included. Variables included in the propensity score match: parity, Kotelchuck index, cesarean delivery, pre-pregnancy diabetes, 
300 gestational diabetes, pre-pregnancy hypertension, gestational hypertension, body mass index (BMI), mother’s age, mother’s education, 
301 mother’s race, delivery year, low birth weight birth, and preterm birth.
302
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303 Appendix Table 1. Propensity score matching variable balance
Matching term
Group 
prenatal 
care
Individual 
prenatal 
care (pre-
matching)
Individual 
prenatal 
care (post-
matching)
Variance 
ratio (pre-
matching)
Variance 
ratio 
(post-
matching)
Parity 0.65 0.97 0.64 0.91 1.07
Kotelchuck index 3.43 2.89 3.37 0.57 0.94
C-section 25.05% 31.48% 24.41% 0.87 1.02
Pre-pregnancy diabetes 0.32% 2.19% 0.23% 0.15 1.40
Gestational diabetes 4.20% 6.18% 4.79% 0.69 0.88
Pre-pregnancy 
hypertension 1.76% 4.44% 1.71% 0.41 1.03
Hypertension 12.63% 10.83% 15.24% 1.14 0.85
BMI 27.81 28.00 27.70 0.76 0.88
Mother's education 1.25 1.29 1.24 1.06 1.09
Mother's age 24.41 25.94 24.34 0.86 1.00
Mother's race 0.69 0.62 0.74 1.17 1.17
Low birth weight 7.48% 9.85% 7.42% 0.78 1.01
Year of birth 2015.56 2015.67 2015.45 0.94 0.87
Preterm birth 7.90% 10.82% 8.15% 0.75 0.97
19
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